Discovery and study on potential effect of herbal pair of Uncariae Ramulus cum Uncis-Eucommiae Cortex on pregnancy hypertension based on network pharmacology and molecular docking.
10.19540/j.cnki.cjcmm.20200810.401
- Author:
Na ZHU
1
;
Zi-Jun SHA
1
;
He JIAN-WU
2
;
Li CAI-FENG
3
;
Feng-Rong ZHANG
4
;
Jun-Qi WANG
1
;
Xiu-Lan HUANG
1
;
Li ZHI-YONG
1
Author Information
1. School of Pharmacy, Minzu University of China Beijing 100081, China.
2. National Joint Engineering Laboratory for Eucommia Utilization, Jishou University Jishou 416000, China.
3. Academician Workstation of Jiangxi University of Traditional Chinese Medicine Nanchang 330004, China.
4. College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine Ji'nan 250355, China.
- Publication Type:Journal Article
- Keywords:
Eucommiae Cortex;
Uncariae Ramulus cum Uncis;
herbal pair;
mechanism;
molecular docking;
network pharmacology;
pregnancy hypertension
- MeSH:
Drugs, Chinese Herbal/pharmacology*;
Humans;
Hypertension/genetics*;
Medicine, Chinese Traditional;
Molecular Docking Simulation;
Pregnancy
- From:
China Journal of Chinese Materia Medica
2020;45(22):5393-5402
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to explore the optimal indications and mechanism of Uncariae Ramulus cum Uncis(UR)-Eucommiae Cortex(EC) in lowering blood pressure based on network pharmacology and molecular docking. Chemical constituents were collected and screened by TCMSP database. Swiss Target Prediction platform was used to predict the related targets of the drug. OMIM, TCMIP and GeneCards databases were used to collect hypertension-related genes, and the intersections were taken to obtain potential targets for anti-hypertensive treatment of UR-EC. FunRich software was used to enrich the clinical phenotype and expression site of potential target of lowering blood pressure to analyze and predict the optimal indications of UR-EC. STRING database was used for KEGG pathway enrichment analysis, and Cytoscape 3.7.2 was used to construct the network of "composition-target-pathway". The key targets and their corresponding components in the network were analyzed and obtained, and then molecular docking was applied for preliminary verification. Twenty potential active components of UR and 24 potential active components of EC were respectively collected, and 92 anti-hypertensive potential targets of UR-EC were obtained. According to FunRich enrichment results, the optimal indication of UR-EC was pregnancy hypertension, which involved calcium signaling pathway, HIF-1 signaling pathway, neuroactive ligand receptor interaction, renin vascular tightening, VEGF signaling pathway, etc. In addition, AKT1, NOS2, ADRB2, F2, NOS3, SCN5 A, HTR2 A and JAK2 were considered as the key targets in the network. The molecular docking results showed that the screened potential active components had high binding activity with the key targets. This study preliminarily revealed that UR-EC may have therapeutic effects on pregnancy hypertension in terms of sedation, anti-hypertension, anti-inflammatory, anti-oxidation, improvement of vascular endothelial function and so on.
